John P. Amboian - 01 Jun 2024 Form 4 Insider Report for Danimer Scientific, Inc. (DNMRQ)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Jun 2024, 17:00:17 UTC
Prior SEC filing
05 Jun 2023
Next SEC filing
22 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen A. Martin, attorney-in-fact

Key filing fact

John P. Amboian filed Form 4 for Danimer Scientific, Inc. (DNMRQ) on 04 Jun 2024.

Key facts

  • This page summarizes John P. Amboian's Form 4 filing for Danimer Scientific, Inc. (DNMRQ).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Jun 2024, 17:00.

Change

  • Previous filing in this sequence was filed on 05 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DNMR transaction

Class A Common Stock

Options Exercise

Transaction value
$0
Shares
+26,578
Change %
Price
$0.000000
Shares after
26,578
Date
01 Jun 2024
Ownership
Direct
DNMR holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
363,943
Date
01 Jun 2024
Ownership
John P. Amboian 2008 Living Trust
Footnotes
F1
DNMR holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
545,915
Date
01 Jun 2024
Ownership
Kings Trail Trust Dtd 09/19/2018
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DNMR transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-26,578
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
26,578
Exercise price
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the pro rata in kind distribution of all of the shares of Common Stock of the Issuer held by Live Oak Sponsor Partners, LLC (the "Sponsor"), without consideration, to its members. The John P. Amboian 2008 Living Trust (the "Living Trust") is a member of the Sponsor, and the Reporting Person is the sole trustee of the Living Trust and therefore the Reporting Person may be deemed to beneficially own the securities held by the Living Trust. The Reporting Person disclaims any beneficial ownership of the reported securities owned by the Living Trust other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Footnote F2

Represents the pro rata in kind distribution of all of the shares of Common Stock of the Issuer held by the Sponsor, without consideration, to its members. Kings Trail Trust Dtd 09/19/2018 (the "Kings Trail Trust") is a member of the Sponsor, and the Reporting Person's spouse is the sole trustee of the Kings Trail Trust and therefore the Reporting Person may be deemed to beneficially own the securities held by the Kings Trail Trust. The Reporting Person disclaims any beneficial ownership of the reported securities owned by the Kings Trail Trust other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of Danimer Scientific Class A common stock.

Footnote F4

Comprised of an award of restricted stock units (RSU) granted as director compensation under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan (the "Plan") with each RSU representing the right to receive one share of Danimer Scientific Class A Common Stock. All of these RSU's will vest and become non-forfeitable on June 1, 2024 subject to recipient's continued service as a director of the Company.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .